Quantech (QQQQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Quantech (QQQQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Phil Lachmann who wrote ()	7/6/1998 2:22:00 PM
From: Michael Pusateri	Read Replies (1) of 338

Quantech wins FDA approval for myoglobin test Reuters, Monday, July 06, 1998 at 13:09 ST. PAUL, Minn., July 6 (Reuters) - Quantech Ltd.(BB:QQQQ) said Monday it received U.S. Food and Drug Administration approval to market its myoglobin test for heart attacks. The company's diagnostic system is designed primarily for hospital emergency rooms to provide rapid quantitative tests. Quantech's first tests will be used to detect and quantify cardiac markers, which help doctors in assessing whether a patent has suffered a heart attack. Quantech said it would not launch this product or other tests into the emergency room testing market until it files for and obtains FDA clearance for the system that reads the results of the tests. "We chose a heart attack test for our first FDA submission because of the large and recognized market for STAT cardiac testing," Robert Case, chief executive, said in a statement. Shares of Quantech were up 1/8 at 2-3/4 early Monday afternoon. chicago.equities.newsroom@reuters.com)) Copyright 1998, Reuters News Service Companies or Securities discussed in this article: Symbol Name BB:QQQQ Quantech Ltd

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next